Thomson Reuters Future of Databases

1
Thomson Reuters Future of Databases

• Academic Government Markets
• Erik-Jan Van-Kleef
• Director of Sales EMEA
• September 2008

2
Scientific Innovation
First online research service
Science Citation Index
Derwent online
Thomson Pharma
Delphion
GENESEQ
IDRAC
1960 1965 1970 1975
1980 1985 1990 1995
2000 2005 2007
Dialog online information retrieval
World Patents Index
MicroPatent
Techstreet
Century of Science
Web of Science
ISI Web of Knowledge Newport Horizon
MDC
Manuscript Management Toolset
3
Current Strategic Position
AG solutions are increasingly being tailored to
address the scholarly research workflow and drive
growth
Major Applications
Discovery
Publishing, Authoring and Collaboration
Performance Evaluation

• Find and validate relevant scientific content
• Identify specialists and collaborators
• Expose evolving research
• Identify authors and institutions uniquely

• Benchmark performance across peer researchers,
  departments, and institutions
• Custom analysis of trends and impact

• Leverage manuscript formatting
• Manage ePeer review
• Simplify collaborative authoring

Core Solutions

Research Services Essential Science Indicators
Web of Knowledge
Manuscript Central EndNote, EndNote Web
Key Customers

• Provost, Minister of Education, Administrator
• Publishers, Editors
• Scientists, Researchers, Scholars

• Scientists, Researchers, Scholars
• Librarians, Information Professionals

• Authors, Patent Applicants
• Publishers, Editors, Reviewers

Core Products
4
AG Market Leadership
Web of Knowledge
Web of Science
Web of Science - double digit growth for 9
consecutive years
49 penetration rate target market
Web of Knowledge used by over 20 million
researchers worldwide
Core content includes Web of Science, Biosis, and
partner resources
Over 58 increase in Web of Knowledge usage in
2007
Global presence up from 50 countries in 2003
to 84 by 2007
Analytical tools, publishing software services
and links with customer content
Introducing regional Chinese citation index and
localized UI
EndNote
Manuscript Central
Manuscript Central delivers e-peer review
solution to publishers
Configurable software-as-service solution adapts
to client workflows
EndNote - 1 reference software in scholarly
writing and publishing
Strong integration with Web of Science, MS Word
and Manuscript Central
5 of 6 top publishers rely on Manuscript Central
Reduces time to publication from months to weeks
Over 2 million cumulative units sold
EndNote Web extends reach to undergrad and mobile
researchers
5
The ISI Web of Knowledge is anchored by Thomson
Scientific premium core content, complemented by
carefully selected partner content, and supported
by powerful tools

• Selected Partner Content
• INSPEC
• CAB Abstracts
• Food Science Technology Abstracts
• MEDLINE

Thomson Scientific Premium Content

• Bibliographic Resources
• Journal Literature
• Web of Science (SCI, SSCI, AHCI)
• Current Contents Connect
• BIOSIS Previews Biological Abstracts
• Zoological Record
• Patents
• Derwent Innovations Index
• Conferences/Proceedings
• ISI Proceedings

• Analytic Resources
• Journal Citation Reports
• Essential Science Indicators
• Research Evaluation Reources
• Citation Reports
• Science Indicators

• Bibliographic Tools
• EndNote
• Reference Manager

6
The Current State

• Total Customers nearly 4,000 in over 80
  countries
• With over 3,900 institution customers,
  significant customer growth in all markets
• Strongest growth in international markets, from
  business in 50 countries (2003) to 84 countries
  (end of 2007)
• 54 of business outside North America

2003-2007
650 customers
1500 customers
250 customers
7
Life Sciences Research
the Present and Future
Within the vast realm of the Life Sciences or
biomedical research there is today extreme
emphasis on integration of fundamental discovery
and its application in clinical medicine
translational science-research-medicine.

• This collaborative, interdisciplinary approach
  among traditional researchers and clinicians
  presents new requirements for supporting
  informational resources.
• What is needed is a diverse collection of
  integrated content delivered within a set of
  tools and features capable of driving fundamental
  discovery as well as supporting the
  decision-making process for clinicians and
  researchers alike.

8
Life Sciences Research
the Present and Future
Therefore Thomson Reuters now presents a
diverse collection of integrated knowledge-bases
in order to serve the molecular biologists,
immunologists, pharmacologists, etc. in the lab
as well as the oncologists, cardiologists,
neurologists, etc. in the clinic.
Adverse Events
Pharmacokinetics
Biomarkers
Clinical Studies
Molecular Therapeutic Targets
Experimental Pharmacology
Drugs and Bioactive Compounds
Genomics
9
Life Sciences Research
the Present and Future true
integration for translational research
These knowledge-bases draw from a wide range of
sources, are supported by Thomson Reuters experts
as well as an international contributor network,
and are complemented by additional content such
as disease briefings and bioinformatics resources.
Conference and Symposia Presentations
Published Research
Bioinformatics Resources
Intellectual Property
Regulatory Information
Clinical Guidelines
Disease Briefings
Adverse Events
Pharmacokinetics
Biomarkers
Clinical Studies
Molecular Therapeutic Targets
Experimental Pharmacology
Genomics
Drugs and Bioactive Compounds
10
Investigator Portal from Thomson Reuters is the
resource to optimize workflow in the
translational research environment. It is the
source of the vast majority of content weve just
presented . Designed to meet the challenges of
interdisciplinary biomedical research.
11
Integration is the key, and Investigator Portal
is designed to link all related information among
its knowledge bases. Here for example this
particular result of a search on Alzheimer
within Therapeutic Targets and Pathways links to
related compounds.
12
In fact, for any search results in any knowledge
base Investigator Portal reveals related
information within all other knowledge
bases. The landscape is quickly identified and
related info accessible.
13
For Academic Researchers in Large Research
Institutes

• Thomson Pharma is a comprehensive global
  pharmaceutical information solution
• Thomson Pharma covers the entire drug discovery
  and development pipeline
• Academic institutions are not in the business of
  making new drugs, but licensing their research
  findings and working with Large Pharma

Discover
Develop
Launch
Innovate
14
Thomson Pharma integrates content from over 40
resources
Patent Data
Commercial Data
Content Integration
Chemistry Data
Literature News Data
Drug Data
Target Data
Gene Sequence Data
15
ContentFormatted into relevant Reports
Content is divided up into 10 concatenated
living reports - derived from over 40 resources
16
Living Records
Sales and Market share information available for
drugs with actual or forecasted sales of 100
million/year (between 2006-2010).
You can see by the graph there is more
competition in the area of diabetes in 2008
Licensing details who owns the rights to the
drug
17
Potential Usage for Academics

• Researchers focused on Drug Discovery or
  Licensing Technology
• Chemistry Report, Target Report etc.
• Integrated content from multiple sources provide
  instantaneous overviews of any topic
• Unique business data
• Research Planning / Funding
• Make the most effective return on research
  investment
• Don't waste resources on topics that already have
  a lot of research investment by the pharma
  industry
• Identify sources of research funding and
  collaboration

18
Life Sciences Research
the Present and Future
There is another layer of information that is
extremely important to those operating within the
research environment.
Biomedical research today is, for most, a
results-driven, competitive, and overall
pressure-filled environment.
Foresight with regard to planning the future
direction of research activities, and the right
people to support these activities, is invaluable.
19
Thomson Scientific
Introducing the Thomson Collexis
Dashboard Providing enhanced knowledge discovery
for the academic and government RD communities.
The Thomson Collexis Dashboard is a text mining
tool to analyze topic areas such as diseases or
drugs, providing expert profiles, trend
information and powerful knowledge discovery. By
merging Thomson Scientifics Web of Science data
with the Collexis Knowledge Dashboard, users will
have the ability to identify and search for
documents, experts and trends, and make new
discoveries more quickly, accurately and deeply
than via conventional search engines.
20
Thomson Scientific
Exploring by Concept is a fundamental benefit of
the Knowledge dashboard.
Here we select Alzheimer Disease as defined by
MeSH, and then Neurofibrillary Tangles as a
subset.
21
Thomson Scientific
The body of papers within the Neurofibrillary
Tangles area is presented. This information can
be explored in a variety of ways -- the
selection of Experts presents top researchers
within this realm.
22
Thomson Scientific
Locations provides a geographic overview, where
research is being produced.
Links to the full records in Web of Science are
presented.
23
Thomson Scientific
Collexis data mining technology identifies hidden
relationships, predicting future areas of study
within Alzheimers Research.
24
Thomson Scientific
Information on particular Researchers may be
retrieved. Identify Experts through Experts
co-authors are revealed, including active and
most prolific.
25
Life Sciences Research
the Present and
Future true content integration to meet the
workflow needs of Life Sciences Researchers
Thomson Collexis Dashboard
Thomson Reuters Life Sciences Resources
Supporting and Driving Discovery, Development,
and Clinical Treatment